Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 7,882,412 $ 10,931,890
Short-term investments 101,032,250 100,842,438
Accounts receivable 71,420 177,239
Prepaid expenses and other current assets 2,845,226 1,842,620
Total Current Assets 111,831,308 113,794,187
Property and Equipment, net 1,766,898 676,262
Other Assets    
In-process R&D 5,866,000 5,866,000
Goodwill 1,452,338 1,452,338
Grant receivable 870,032  
Operating lease right-of-use asset 1,885,681 2,035,882
Finance lease right-of-use asset 533,561 247,194
Other assets 8,199,850  
Deposits 249,557 122,779
Total Other Assets 19,057,019 9,724,193
Total Assets 132,655,225 124,194,642
Current Liabilities    
Accounts payable 1,065,663 1,051,764
Deferred revenue, current portion 603,717
Operating lease liability, current portion 341,977 278,753
Finance lease liability, current portion 222,313 108,127
Accrued expenses and other liabilities 1,660,288 1,614,534
Total Current Liabilities 3,290,241 3,656,895
Long Term Liabilities    
Other long-term liabilities 50,511 36,243
Derivative warrant liability 30,971 33,779
Deferred tax liability 361,911 361,911
Deferred revenue, net of current portion 237,500 237,500
Operating lease liability, net of current portion 1,152,008 1,301,636
Financing lease liability, net of current portion 348,128 160,240
Contingent consideration 2,564,608 2,250,844
Contingent consideration, related party 753,907 661,671
Total Liabilities 8,789,785 8,700,719
Commitments and Contingencies
Stockholders' Equity    
Common stock, $.0002 par value; 250,000,000 and 250,000,000 shares authorized, 25,143,315 and 22,592,500 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 5,028 4,519
Additional paid-in capital 277,097,787 247,048,349
Accumulated deficit (152,155,580) (130,647,485)
Accumulated other comprehensive loss (52,545) (166,056)
Total Stockholders' Equity - Heat Biologics, Inc. 124,894,690 116,239,327
Non-Controlling Interest (1,029,250) (745,404)
Total Stockholders' Equity 123,865,440 115,493,923
Total Liabilities and Stockholders' Equity $ 132,655,225 $ 124,194,642